Post-Market Surveillance (PMS/PMCF)
Available Plans
Pro / Max / CRO
Overview
EU MDR mandates comprehensive post-market surveillance. Reguverse provides complete PMS workflows from planning to reporting.
Available Workflows
| Workflow | Description | Output |
|---|---|---|
| PMS Plan | Post-market surveillance planning | PMS Plan document |
| PMCF Plan | Post-market clinical follow-up planning | PMCF Plan document |
| CE Update | Periodic clinical evaluation update | Updated CER |
| PMCF Report | PMCF evaluation report | PMCF Report |
| PSUR | Periodic Safety Update Report | PSUR document |
PMS Plan
Defines post-market monitoring strategy including adverse event monitoring, FSCA procedures, trend reporting, and complaint handling.
PMCF Plan
Defines post-market clinical data collection strategy: objectives, data sources, analysis methods, endpoints, and timelines.
CE Update
Periodic clinical evaluation updates incorporating latest safety and performance data, comparing against previous literature pools, and updating benefit-risk conclusions.
PMCF Report
Evaluation report based on PMCF activities: data collection summary, clinical data analysis, safety conclusions, and recommendations.
PSUR
Periodic safety update reports as required by EU MDR: safety data summary, adverse event analysis, corrective actions, and benefit-risk reassessment.
Regulatory Requirements
- Class IIa and above: PSUR at least annually
- Class III and implants: PSUR submitted to EUDAMED
- Class I: PMS report as needed (not PSUR)
